Skip to main content

Aura Biosciences, Inc. (AURA)

NASDAQ: AURA · IEX Real-Time Price · USD
18.03 0.59 (3.38%)
Dec 1, 2021 11:49 AM EST - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019
Selling, General & Admin
4.164.52
Research & Development
18.0419.62
Operating Expenses
22.2124.14
Operating Income
-22.21-24.14
Interest Expense / Income
00.01
Other Expense / Income
-00.06
Pretax Income
-22.21-24.2
Net Income
-22.21-24.2
Preferred Dividends
7.936.03
Net Income Common
-30.13-30.23
Shares Outstanding (Basic)
55
Shares Outstanding (Diluted)
55
Shares Change
8.55%-
EPS (Basic)
-5.99-6.52
EPS (Diluted)
-5.99-6.52
Free Cash Flow Per Share
-4.99-4.94
EBITDA
-21.37-23.69
EBIT
-22.2-24.2
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).